Cristhian H Aristizábal-Duque

Mr. Cristhian H Aristizábal-Duque

Hospital Clínico Universitario de Valladolid, Valladolid, Castille-Leon, Spain
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2021 in Heart
Verified
Journal Article
Closed access
PDF file
JDJose R Delgado-Arana
Jose R Delgado-Arana
MGMaría X Gordillo-Monge
María X Gordillo-Monge
JHJonathan Halim
Jonathan Halim
FMFederico De Marco
Federico De Marco
CTCarlo Trani
Carlo Trani
Ignacio J. Amat-SantosIgnacio J. Amat-Santos
Ignacio J. Amat-Santos
Objectives The balloon-expandable Sapien-3 valve demonstrated superior results in terms of residual aortic regurgitation when compared with self-expandable devices. We aimed to compare for the first-time early outcomes of Sapien-3 transcatheter heart valve (THV) with the balloon-expandable Myval device. Methods Consecutive real-world patients from nine European institutions with symptomatic severe aortic stenosis treated either with Sapien-3 or Myval THV devices after June 2018 were compared. Early clinical outcomes were prospectively gathered and blinded analysis of 30-day echocardiography was conducted. Matching for the following variables was performed: age, body surface area, Society of Thoracic Surgeons risk score, left ventricular function, mean gradient, transfemoral approach, aortic valvular calcium, aortic annulus mean diameter, area and eccentricity index. Results A total of 416 patients treated either with the Sapien-3 (n=286, 68.7%) or with Myval THV (n=130, 31.3%) were included and 103 pairs compared after matching. Baseline characteristics were similar. Procedural success rate (Sapien-3: 94.2%; Myval: 93.2%, p=0.219), 30-day mortality (Sapien-3: 2.9%; Myval: 0.97%, p=0.625), clinical efficacy (12.6 vs 4.9%, p=0.057) and early safety (12.6 vs 4.9%, p=0.096) were comparable. There was a lower need for new permanent pacemaker (15.5 vs 5.8% p=0.020) with Myval. No significant differences were found in terms of ≥moderate aortic regurgitation (1% for Sapien-3, 0% for Myval, p=0.314), but mean gradients were higher following Sapien-3 than after Myval (p<0.001). Conclusions The new Myval balloon-expandable THV was favourable in terms of safety, with low rate of permanent pacemaker and with favourable residual gradients and paravalvular leak rate according to blinded echocardiographic analysis.

18 May 2016 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
PDF file
MLMarcela Lonngi
Marcela Lonngi
MAMaría Camila Aguilar
María Camila Aguilar
HRHernán Andrés Ríos
Hernán Andrés Ríos
CACristhian H Aristizábal-Duque
Cristhian H Aristizábal-Duque
FRFrancisco José Rodríguez
Francisco José Rodríguez
MDMd
Md
Purpose: To describe the clinical features of uveitis in children treated at two ophthalmologic centers in Bogotá, Colombia, in a 13 year-period. Methods: Retrospective observational clinical record review of pediatric children with diagnosis of uveitis. Results: In total, 310 children were evaluated, 51.9% were female, mean age of 10.1 years. Posterior uveitis was the most common location (58.7%), of insidious onset (87.4%) and chronic course (78.1%). The most common etiology was infection (58.4%) caused by toxoplasmosis (76.8%). There was a statistically significant difference in visual acuity between anterior (20/68) and intermediate uveitis (20/70), compared with posterior uveitis (20/434) (p<0.05). Conclusions: This is the first study to report the clinical features of pediatric uveitis in Colombia, where infectious etiologies are the leading cause. It will improve awareness and knowledge of pediatric uveitis in developing countries, and contribute to the development of public health policies of pediatric visual health.

14 August 2021 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
MGMario García Gómez
Mario García Gómez
JDJose Raúl Delgado‐Arana
Jose Raúl Delgado‐Arana
JHJonathan Halim
Jonathan Halim
FMFederico De Marco
Federico De Marco
CTCarlo Trani
Carlo Trani
Ignacio J. Amat-SantosIgnacio J. Amat-Santos
Ignacio J. Amat-Santos

25 January 2022 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
JCJuan Fernández Cabeza
Juan Fernández Cabeza
CACristhian H Aristizábal-Duque
Cristhian H Aristizábal-Duque
ISIsabel María Blancas Sánchez
Isabel María Blancas Sánchez
MOMartín Ruíz Ortiz
Martín Ruíz Ortiz
AAAna Rodríguez Almodóvar
Ana Rodríguez Almodóvar
MRMaría Dolores Mesa Rubio
María Dolores Mesa Rubio

2 September 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SBSara Blasco-Turrión
Sara Blasco-Turrión
AFANA MARIA SERRADOR FRUTOS
ANA MARIA SERRADOR FRUTOS
JJJohn Jose
John Jose
GSGunasekaran Sengotuvelu
Gunasekaran Sengotuvelu
ASAshok Seth
Ashok Seth
Ignacio J. Amat-SantosIgnacio J. Amat-Santos
Ignacio J. Amat-Santos
Background: The vast majority of transcatheter valve-in-valve (ViV) mitral procedures have been reported with the SAPIEN family. We aimed to report the preliminary experience with the Myval balloon-expandable device in this setting. Methods: Multicenter retrospective study of high-risk surgical patients with mitral bioprosthesis degeneration undergoing transcatheter ViV implantation with Myval device. Results: A total of 11 patients from five institutions were gathered between 2019 and 2022 (age 68 ± 7.8, 63% women). The peak and mean transvalvular gradients were 27 ± 5 mmHg and 14.7 ± 2.3 mmHg, respectively, and the predicted neo-left ventricular outflow tract (neo-LVOT) area was 183.4 ± 56 mm2 (range: 171 to 221 mm2). The procedures were performed via transfemoral access in all cases (through echocardiography-guided transeptal puncture (81.8% transesophageal, 11.2% intracardiac)). Technical success was achieved in all cases, with no significant residual mitral stenosis in any of them (peak 7.2 ± 2.7 and mean gradient 3.4 ± 1.7 mmHg) and no complications during the procedure. There were no data of LVOT obstruction, migration, or paravalvular leak in any case. Mean hospital stay was 3 days, with one major vascular complication and no stroke. At 6-month follow-up, there was one case with suboptimal anticoagulation presenting an increase in the transmitral gradients (mean 15 mmHg) that normalized after optimization of the anticoagulation, but no other relevant events. Conclusions: Transseptal ViV mitral implantation with the balloon-expandable Myval device was feasible and safe avoiding redo surgery in high-risk patients with bioprosthesis degeneration.

Verified
Journal Article
Open access
PDF file
CACristhian H Aristizábal-Duque
Cristhian H Aristizábal-Duque
JCJuan Fernández Cabeza
Juan Fernández Cabeza
ISIsabel María Blancas Sánchez
Isabel María Blancas Sánchez
MOMónica Delgado Ortega
Mónica Delgado Ortega
PAPilar Aparicio-Martinez
Pilar Aparicio-Martinez
DRDolores Mesa Rubio
Dolores Mesa Rubio
Background: Two-dimensional speckle-tracking echocardiography (2DSTE) has been present for years. However, it is underutilized due to the expertise and time requirements for its analysis. Our aims were to provide strain values in a paediatric Spanish population and to assess the feasibility and reproducibility of a new strain software analysis in our environment. Methods: A cross-sectional study of 156 healthy children aged 6 to 17 years. Longitudinal strain (LS) analysis of the left ventricle, right ventricle, and left atrium was performed. Feasibility and reproducibility were assessed. The associations of clinical and echocardiographic variables with strain values were investigated by multivariate analysis. Results: Mean age was 11 ± 3 years (50% female). Feasibility of LS measurement ranged from 94.2% for left ventricle global LS (LVGLS) to 98.1% for other chamber strain parameters. Strain values were 26.7 ± 2.3% for LVGLS; 30.5 ± 4.4% and 26.9 ± 4% for right ventricle free wall LS (RVFWLS) and four chambers view LS (RV4CLS) respectively; and 57.8 ± 10.5%, 44.9 ± 9.5%, and 12.9 ± 5.5% for left atrium LS reservoir phase (LALSr), conduct phase (LALScd) and contraction phase (LALSct), also respectively. Body surface area (BSA) and age presented a negative correlation with strain values. Higher values were found in females than in males, except for LALScd. Excellent intra- and inter-observer reproducibility were found for right and left ventricular strain measurement, with intraclass correlation coefficients (ICC) ranging from 0.88 to 0.98, respectively. In conclusion, we described strain values in a healthy Spanish paediatric population. LS assessment by this new strain analysis software by semi-automatic manner was highly feasible and reproducible.